Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT
· Real-Time Price · USD
2.40
-0.09 (-3.61%)
At close: May 23, 2025, 3:59 PM
2.40
0.10%
After-hours: May 23, 2025, 05:54 PM EDT
-3.61% (1D)
| Bid | 2.36 |
| Market Cap | 31.78K |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.24M |
| EPS (ttm) | -49.9 |
| PE Ratio (ttm) | -0.05 |
| Forward PE | -1.43 |
| Analyst | Buy |
| Ask | 2.54 |
| Volume | 14,607 |
| Avg. Volume (20D) | 102,692 |
| Open | 2.47 |
| Previous Close | 2.49 |
| Day's Range | 2.39 - 2.47 |
| 52-Week Range | 2.00 - 20.60 |
| Beta | 0.56 |
About PPBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PPBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PPBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-5.14%
PPBT stock has given up its prior gain. Purple Bio...
Unlock content with
Pro Subscription
3 weeks ago
-5.14%
Purple Biotech shares are trading higher after the company's CM24 showed up to a 90% reduction in the death risk for pancreatic cancer patients and announced it will commence a Phase 2b study.
